{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,20]],"date-time":"2026-05-20T04:47:46Z","timestamp":1779252466246,"version":"3.51.4"},"reference-count":27,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2017,5,1]],"date-time":"2017-05-01T00:00:00Z","timestamp":1493596800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["tuberculosisjournal.com","clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.fr","clinicalkey.com.au","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Tuberculosis"],"published-print":{"date-parts":[[2017,5]]},"DOI":"10.1016\/j.tube.2017.02.004","type":"journal-article","created":{"date-parts":[[2017,2,21]],"date-time":"2017-02-21T02:02:15Z","timestamp":1487642535000},"page":"24-29","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":20,"special_numbering":"C","title":["Activity of rifampicin and linezolid combination in Mycobacterium tuberculosis"],"prefix":"10.1016","volume":"104","author":[{"given":"Flaviane Granero","family":"Maltempe","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Katiany Rizzieri","family":"Caleffi-Ferracioli","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Renata Claro Ribeiro","family":"do Amaral","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fernanda","family":"de Oliveira Demitto","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Vera L\u00facia Dias","family":"Siqueira","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Regiane Bertin","family":"de Lima Scodro","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M\u00e1rio Hiroyuki","family":"Hirata","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fernando Rog\u00e9rio","family":"Pavan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rosilene Fressatti","family":"Cardoso","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.tube.2017.02.004_bib1","series-title":"Global tuberculosis report 2014","author":"WHO. World Health Organization","year":"2014"},{"key":"10.1016\/j.tube.2017.02.004_bib2","doi-asserted-by":"crossref","first-page":"2100","DOI":"10.1016\/S0140-6736(10)60359-9","article-title":"Global tuberculosis drug development pipeline: the need and the reality","volume":"375","author":"Ma","year":"2010","journal-title":"Lancet"},{"key":"10.1016\/j.tube.2017.02.004_bib3","first-page":"h882","article-title":"Multidrug resistant tuberculosis","volume":"350","author":"Millard","year":"2015","journal-title":"Clin Rev BMJ"},{"issue":"4","key":"10.1016\/j.tube.2017.02.004_bib4","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/S0196-4399(02)80003-4","article-title":"Linezolid: the first of a new class of antimicrobial agents","volume":"24","author":"Zabransky","year":"2012","journal-title":"Clin Microbiol News Lett"},{"issue":"5","key":"10.1016\/j.tube.2017.02.004_bib5","doi-asserted-by":"crossref","first-page":"1189","DOI":"10.1128\/AAC.43.5.1189","article-title":"Activities of several novel oxazolidinones against Mycobacterium tuberculosis in a murine model","volume":"43","author":"Cynamom","year":"1999","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.tube.2017.02.004_bib6","doi-asserted-by":"crossref","first-page":"416","DOI":"10.1128\/AAC.47.1.416-417.2003","article-title":"In\u00a0vitro activities of linezolid against clinical isolates of Mycobacterium tuberculosis that are susceptible or resistant to first-line antituberculosous drugs","volume":"47","author":"Alcala","year":"2003","journal-title":"Antimicrob Agents Chemother"},{"issue":"3","key":"10.1016\/j.tube.2017.02.004_bib7","doi-asserted-by":"crossref","first-page":"764","DOI":"10.1128\/AAC.45.3.764-767.2001","article-title":"Activities of linezolid against rapidly growing mycobacteria","volume":"43","author":"Wallace","year":"2001","journal-title":"Antimicrob Agents Chemother"},{"issue":"6","key":"10.1016\/j.tube.2017.02.004_bib8","doi-asserted-by":"crossref","first-page":"950","DOI":"10.1093\/jac\/dki111","article-title":"In\u00a0vitro activity of linezolid, claritomycin and moxifloxacin against clinical isolates of mycobacterium kansassi","volume":"55","author":"Guna","year":"2005","journal-title":"J\u00a0Antimicrob Chemother"},{"issue":"5","key":"10.1016\/j.tube.2017.02.004_bib9","doi-asserted-by":"crossref","first-page":"1736","DOI":"10.1128\/AAC.47.5.1736-1738.2003","article-title":"In\u00a0vitro activity of linezolid againt slowly growing nontuberculous mycobacteria","volume":"47","author":"Brown-Elliott","year":"2003","journal-title":"Antimicrob Agents Chemother"},{"issue":"1","key":"10.1016\/j.tube.2017.02.004_bib10","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1016\/j.ijantimicag.2008.06.014","article-title":"Daily half-dose linezolid for the treatment of intractable multidrug-resistant tuberculosis","volume":"33","author":"Nam","year":"2009","journal-title":"Int J Antimicrob Agents"},{"issue":"6","key":"10.1016\/j.tube.2017.02.004_bib11","doi-asserted-by":"crossref","first-page":"2226","DOI":"10.1128\/AAC.00414-07","article-title":"In\u00a0vitro activities of linezolid against clinical isolates of Mycobacterium tuberculosis complex isolated in Taiwan over 10 years","volume":"52","author":"Huang","year":"2008","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.tube.2017.02.004_bib12","first-page":"217","article-title":"M\u00e9sure de la sensibilit\u00e9 du bacilli tuberculeux aux drogues antibacilares par la m\u00e9thode des proportions","volume":"27","author":"Canetti","year":"1963","journal-title":"Rev Tuberc Pneumol"},{"key":"10.1016\/j.tube.2017.02.004_bib13","doi-asserted-by":"crossref","first-page":"4498","DOI":"10.1128\/JCM.01392-06","article-title":"Proposal for standardization of optimized mycobacterial interspersed repetitive unit-variable-number tandem repeat typing of Mycobacterium tuberculosis","volume":"44","author":"Supply","year":"2006","journal-title":"J\u00a0Clin Microbiol"},{"key":"10.1016\/j.tube.2017.02.004_bib14","first-page":"381","article-title":"Rapid detection and simultaneous strain differentiation of Mycobacterium tuberculosis complex bacteria by spoligotyping","volume":"101","author":"Molhuizem","year":"1998","journal-title":"Methods Mol Biol"},{"issue":"8","key":"10.1016\/j.tube.2017.02.004_bib15","doi-asserted-by":"crossref","first-page":"2720","DOI":"10.1128\/AAC.46.8.2720-2722.2002","article-title":"Resazurin microtitre assay plate: simple and inexpensive method for detection of drug resistance in Mycobacterium tuberculosis","volume":"46","author":"Palomino","year":"2002","journal-title":"Antimicrob Agents Chemother"},{"issue":"6","key":"10.1016\/j.tube.2017.02.004_bib16","doi-asserted-by":"crossref","first-page":"600","DOI":"10.1016\/j.tube.2013.09.001","article-title":"Fast detection of drug interaction in Mycobacterium tuberculosis by a checkerboard resazurin method","volume":"93","author":"Caleffi-Ferracioli","year":"2013","journal-title":"Tuberculosis"},{"key":"10.1016\/j.tube.2017.02.004_bib17","series-title":"Antibiotics in laboratory medicine","first-page":"365","article-title":"Antimicrobial combinations","author":"Pillai","year":"2003"},{"issue":"4","key":"10.1016\/j.tube.2017.02.004_bib18","first-page":"719","article-title":"An investigation of the antimicrobial impact of drug combinations against Mycobacterium tuberculosis strains","volume":"41","author":"Limoncu","year":"2011","journal-title":"Turk J Med Sci"},{"issue":"5","key":"10.1016\/j.tube.2017.02.004_bib19","doi-asserted-by":"crossref","first-page":"384","DOI":"10.7883\/yoken.JJID.2009.384","article-title":"In\u00a0vitro activity of linezolid against Mycobacterium tuberculosis strains isolate from western Turkey","volume":"62","author":"Ermertcan","year":"2009","journal-title":"Jpn J Infect Dis"},{"issue":"3","key":"10.1016\/j.tube.2017.02.004_bib20","doi-asserted-by":"crossref","first-page":"1287","DOI":"10.1128\/AAC.01297-10","article-title":"Susceptibility of clinical Mycobacterium tuberculosis isolates to a potentially less toxic derivate of linezolid, PNU-100480","volume":"55","author":"Alffenaar","year":"2011","journal-title":"Antimicrob Agents Chemother"},{"issue":"3","key":"10.1016\/j.tube.2017.02.004_bib21","doi-asserted-by":"crossref","first-page":"240","DOI":"10.7883\/yoken.65.240","article-title":"In\u00a0vitro activity of linezolid against clinical isolates of Mycobacterium tuberculosis, including multidrug-resistant and extensively drug-resistant strains from Beijing, China","volume":"65","author":"Yang","year":"2012","journal-title":"Jpn J Infect Dis"},{"issue":"4","key":"10.1016\/j.tube.2017.02.004_bib22","doi-asserted-by":"crossref","first-page":"354","DOI":"10.1016\/S0924-8579(02)00387-4","article-title":"Synergic activity of fluoroquinolones and linezolid against Mycobacterium tuberculosis","volume":"21","author":"Rodriguez D\u00edaz","year":"2003","journal-title":"Int J Antimicrob Agents"},{"issue":"43","key":"10.1016\/j.tube.2017.02.004_bib23","first-page":"293","article-title":"Effect of linezolid in combination with isoniazid and rifampicin against multidrug resistant Mycobacterium tuberculosis clinical isolates","volume":"2","author":"Coban","year":"2009","journal-title":"Mikrobiyol Bul"},{"issue":"12","key":"10.1016\/j.tube.2017.02.004_bib24","doi-asserted-by":"crossref","first-page":"2582","DOI":"10.1093\/jac\/dkq374","article-title":"Time\u2013kill kinetics of anti-tuberculosis drugs, and emergence of resistance, in relation to metabolic activity of Mycobacterium tuberculosis","volume":"65","author":"de Steenwinkel","year":"2010","journal-title":"J\u00a0Antimicrob Chemother"},{"issue":"6","key":"10.1016\/j.tube.2017.02.004_bib25","doi-asserted-by":"crossref","first-page":"509","DOI":"10.7883\/yoken.64.509","article-title":"Efficacy and safety of linezolid in the treatment of extensively drug-resistant tuberculosis","volume":"64","author":"Tangg","year":"2011","journal-title":"Jpn J Infect Dis"},{"issue":"3","key":"10.1016\/j.tube.2017.02.004_bib26","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1056\/NEJMc1500286","article-title":"Linezolid for XDR-TB\u2013final study outcomes","volume":"373","author":"Lee","year":"2015","journal-title":"N\u00a0Engl J Med"},{"issue":"16","key":"10.1016\/j.tube.2017.02.004_bib27","doi-asserted-by":"crossref","first-page":"1508","DOI":"10.1056\/NEJMoa1201964","article-title":"Linezolid for treatment of chronic extensively drug-resistant tuberculosis","volume":"367","author":"Lee","year":"2012","journal-title":"N\u00a0Engl J Med"}],"container-title":["Tuberculosis"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1472979216304553?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1472979216304553?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2023,8,22]],"date-time":"2023-08-22T04:56:26Z","timestamp":1692680186000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1472979216304553"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,5]]},"references-count":27,"alternative-id":["S1472979216304553"],"URL":"https:\/\/doi.org\/10.1016\/j.tube.2017.02.004","relation":{},"ISSN":["1472-9792"],"issn-type":[{"value":"1472-9792","type":"print"}],"subject":[],"published":{"date-parts":[[2017,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Activity of rifampicin and linezolid combination in Mycobacterium tuberculosis","name":"articletitle","label":"Article Title"},{"value":"Tuberculosis","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.tube.2017.02.004","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}